NCT01645098View on ClinicalTrials.gov

Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG

Ketamine

1 mg/kg IV, additional doses of 0.5 mg/kg as needed

DRUG

Dexmedetomidine

0.5 mcg/kg/hr IV

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT01645098 - Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy | Biotech Hunter | Biotech Hunter